Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Tuesday, August 26, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
7092 POSTS
0 Comments
https://blstimes.com
Life Sciences
Covid antibodies spike in breast milk after vaccination: Study
Life Sciences Times
-
April 7, 2021
0
Public Health
‘All US adults will be eligible for vax by April 19’
Life Sciences Times
-
April 7, 2021
0
Public Health
AstraZeneca’s UK vaccine trial on kids comes to a halt
Life Sciences Times
-
April 7, 2021
0
Public Health
Better masks, adequate ventilation must to curb Covid indoors
Life Sciences Times
-
April 7, 2021
0
People on the Move
Spectrum Solutions Names Rohit K. Gupta as Chief Medical Officer
Life Sciences Times
-
April 6, 2021
0
Public Health
Quidel Taps ICS to Collaborate on Next-Gen Diagnostic Instruments for COVID Pathogen Detection
Life Sciences Times
-
April 6, 2021
0
Venture Capital
David Evans Shaw Invests in Maxwell Biosciences
Life Sciences Times
-
April 6, 2021
0
Public Health
Design a cheap, innovative face mask & win up to $500,000
Life Sciences Times
-
April 6, 2021
0
Pharma
BP pills may raise heart disease risk in people with HIV: Study
Life Sciences Times
-
April 5, 2021
0
Pharma
New five-minute treatment for breast cancer rolled out in UK
Life Sciences Times
-
April 5, 2021
0
1
...
676
677
678
...
710
Page 677 of 710
TOP AUTHORS
Life Sciences Times
7092 POSTS
0 Comments
https://blstimes.com
Most Read
India’s Hyderabad Among World’s Top Seven Life Sciences Clusters
August 26, 2025
ProVerum Raises $80 Million in Series B to Advance Commercialization of BPH Treatment
August 25, 2025
Cambrex Expands Peptide Manufacturing Capabilities at Waltham, Massachusetts Facility
August 25, 2025
Merz Therapeutics Begins Phase III Trials of XEOMIN® for Migraine Prevention
August 25, 2025